BioArctic Partners With Eli Lilly Over Potential New Treatment To Combine BrainTransporter Technology with Lilly's Undisclosed Drug Candidate In Neurodegeneration; BioArctic Eligible To Receive $30M Upfront Payment

뉴스 본문을 불러오고 있어요.

BioArctic Partners With Eli Lilly Over Potential New Treatment To Combine BrainTransporter Technology with Lilly's Undisclosed Drug Candidate In Neurodegeneration; BioArctic Eligible To Receive $30M Upfront Payment | 웨이프 WAPE

BioArctic Partners With Eli Lilly Over Potential New Treatment To Combine BrainTransporter Technology with Lilly's Undisclosed Drug Candidate In Neurodegeneration; BioArctic Eligible To Receive $30M Upfront Payment

기사 요약

관련 종목

댓글 —